Herna Verhagen - Actelion Member of the Board of Directors

Director

Ms. Herna W.P.M.A. Verhagen was Member of the Board of Directors of Actelion Ltd since May 8, 2015. She is Member of the Compensation Committee at the Company. She became Chief Executive Officer of PostNL N.V., a mail, parcel and ecommerce corporation, in April 2012. Prior to this Ms. Verhagen served as Member of the Board of Management of PostNL N.V. and held various executive positions within the Group. Ms. Verhagens portfolio includes corporate strategy, public affairs, communications, corporate responsibility, human resources and internal audit. Ms. Verhagen holds a MSc in Human Resource Studies and a LLM in Business Law. Ms. Verhagen has served at the Supervisory Board of Rexel S.A. and was Member of the Executive Committee and General Board of the Confederation of Netherlands Industry and Employers . since 2015.
Age 50
Tenure 9 years
Phone41 61 565 65 65
Webhttp://www.actelion.com

Actelion Management Efficiency

The company has return on total asset (ROA) of 23.87 % which means that it generated a profit of $23.87 on every $100 spent on assets. This is very large. Similarly, it shows a return on equity (ROE) of 47.08 %, meaning that it generated $47.08 on every $100 dollars invested by stockholders. Actelion's management efficiency ratios could be used to measure how well Actelion manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Nicola MendelsohnDiageo PLC ADR
47
Siobhan MoriartyDiageo PLC ADR
54
Arthur EastlyAKITA Drilling
78
C SpitznagelAKITA Drilling
57
Harish MohanAKITA Drilling
61
Dale RichardsonAKITA Drilling
71
Mary RicciardelloNoble plc
63
Stanley SheridanNational Beverage Corp
73
Melissa BethellDiageo PLC ADR
46
Ireena VittalDiageo PLC ADR
51
Chad DeatonTransocean
61
Henry WilmotAKITA Drilling
60
John CummingCrimson Wine
48
Gordon HallNoble plc
61
Ursula BurnsDiageo PLC ADR
59
Frederick MohnTransocean
43
Douglas DafoeAKITA Drilling
60
Julie EdwardsNoble plc
62
Martin McNamaraTransocean
68
Vanessa ChangTransocean
67
Susan KilsbyDiageo PLC ADR
62
Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes low molecular weight drugs for unmet medical needs. The company was founded in 1997 and is headquartered in Allschwil, Switzerland. Actelion Ltd is traded on OTC Market in USA. Actelion Ltd UNSP [ALIOY] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Actelion UNSP Leadership Team

Elected by the shareholders, the Actelion's board of directors comprises two types of representatives: Actelion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Actelion. The board's role is to monitor Actelion's management team and ensure that shareholders' interests are well served. Actelion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Actelion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rudi Frank, Senior Vice President Head Global Quality Management, Member of the Extended Executive Committee
Marian Borovsky, Senior Vice President Group General Counsel, Member of the Extended Executive Committee, Corporate Secretary to the Board of Directors
Thomas Widman, Co-Founder
Nicholas Franco, Executive Vice President Chief Business Development Officer, Member of the Executive Committee
Christian Albrich, Senior Vice President Head Global Human Resources and a member of the Extended Actelion Executive Committee
Martine Clozel, Senior Vice President Chief Scientific Officer, Head of Drug Discovery, Pharmacology & Preclinical Development, Member of the Extended Executive Committee
Robert Bertolini, Member of the Board of Directors
Juhani Anttila, Member of the Board of Directors
JeanPierre Garnier, Chairman of the Board of Directors
David Stout, Member of the Board of Directors
JeanPaul Clozel, CEO, Member of the Executive Committee, Delegate of the Board of Directors
Guy Braunstein, Executive Vice President Head of Global Clinical Development, Member of the Executive Committee
Herna Verhagen, Member of the Board of Directors
Andrew Weiss, Senior Vice President Head Investor Relations and Corporate Communications, Member of the Extended Executive Committee
Michael Jacobi, Member of the Board of Directors
Jean Malo, Member of the Board of Directors
Otto Schwarz, COO, Executive Vice President Member of the Executive Committee
Andre Muller, CFO, Executive Vice President Member of the Executive Committee
Peter Gruss, Member of the Board of Directors
John Greisch, Member of the Board of Directors

Actelion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Actelion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Actelion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Actelion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actelion will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Equifax could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equifax when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equifax - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equifax to buy it.
The correlation of Equifax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equifax moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equifax moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equifax can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Actelion Pink Sheet

If you are still planning to invest in Actelion UNSP check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Actelion's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios